Please login to the form below

I have forgotten my password

The best work in healthcare communications shines at virtual Communiqué Awards

Cx 2020 virtual awards

First virtual awards takes social media by storm

Mearns & Pike, Electric Putty and Evoke KYNE make a clean sweep at Communiqué 2020

Respective projects for Crohn’s and Colitis UK win across the board

NHS test and trace system ‘still not good enough’ says health leader

Test and trace system falls short in latest figures

Communiqué Awards 2020

Watch the event live from 4pm today – join us at pmlive.com/cxhealth

Abivax doses first patient in phase 2b/3 COVID-19 clinical trial

Study will evaluate experimental anti-inflammatory drug

Pfizer jumps on early data from BioNTech-partnered COVID-19 vaccine study

Preliminary data demonstrates promising immunogenicity

Inovio slips on “positive results” for COVID-19 vaccine

Lack of clear information in first human data raises questions

Spending by pharma on UK R&D increased last year

Data shows third annual increase in a row

Novo Nordisk gets another OK for oral GLP-1 drug Rybelsus

Drug is first and so far only oral alternative to injectable GLP-1 agonists

Q&A: Kate Callan

Q&A: Kay Wesley

PME chats to the Chief Executive of Kanga Health Ltd and Town Councillor at Women’s Equality Party Congleton
Q&A: Elizabeth Egan

Elizabeth Egan is President of Havas Lynx Group

New Japanese approvals include first OK for GSK’s anaemia drug Duvroq

And Novartis gets green light for non-small cell lung cancer drug Tabrecta
Novartis pulls EU filing for $3.4bn eye therapy Xiidra

Company says EMA’s concerns “could not be addressed within the available timeframe”
BMS scores EU okay for first-in-class anaemia drug Reblozyl

Drug is one of five of Celgene’s late-stage pipeline drugs with blockbuster potential
Remdesivir closes in on receiving first EU approval for treatment for COVID-19

First drug shown to have an effect on COVID-19 in controlled clinical trials
Novartis agrees $347m settlement for bribery allegations

Settlements involve bribery schemes in Greece and Vietnam
Early knockback for AbbVie as FDA rejects Allergan eye drug

Drug as effective as rival Novartis’ drug but has more side effects
NICE knocks back Novartis’ oral MS drug Mayzent in draft guidance

Drug has been found to reduce disability progression by 33%

Latest appointments

Syneos Health appoints trio of senior hires

Ian Dorrian, JD Cassidy and Maria Tender bolster senior leadership team
Syneos Health appoints Tim Pantello as president of communications

Brings nearly 25 years of experience across strategy, marketing and technology
Dan Russell joins Seven Stones as managing director

Joins the team to help drive global expansion
McCann Health France strengthens team with two new hires

Melissa Brunet and Christelle David-Basei join the agency
Ashfield appoints new global head of quality and compliance

Internal candidate Carey Galvin to take on the role

More appointments

Communiqué Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

The search for treatments for Parkinson’s disease: The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.: Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials: As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Quick links

Infographics

Multimedia

<>